Thompson CB - Search Results

1

Akt stimulates aerobic glycolysis in cancer cells.

Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB. Elstrom RL, et al. Among authors: thompson cb. Cancer Res. 2004 Jun 1;64(11):3892-9. doi: 10.1158/0008-5472.CAN-03-2904. Cancer Res. 2004. PMID: 15172999

2

Expression of bcl-xL can confer a multidrug resistance phenotype.

Minn AJ, Rudin CM, Boise LH, Thompson CB. Minn AJ, et al. Among authors: thompson cb. Blood. 1995 Sep 1;86(5):1903-10. Blood. 1995. PMID: 7655019 Free article.

3

Apoptosis and disease: regulation and clinical relevance of programmed cell death.

Rudin CM, Thompson CB. Rudin CM, et al. Among authors: thompson cb. Annu Rev Med. 1997;48:267-81. doi: 10.1146/annurev.med.48.1.267. Annu Rev Med. 1997. PMID: 9046961 Review.

4

Apoptotic signaling in lymphocytes.

Rudin CM, Van Dongen J, Thompson CB. Rudin CM, et al. Among authors: thompson cb. Curr Opin Hematol. 1996 Jan;3(1):35-40. doi: 10.1097/00062752-199603010-00006. Curr Opin Hematol. 1996. PMID: 9372049 Review.

5

A Bcl-xL transgene promotes malignant conversion of chemically initiated skin papillomas.

Pena JC, Rudin CM, Thompson CB. Pena JC, et al. Among authors: thompson cb. Cancer Res. 1998 May 15;58(10):2111-6. Cancer Res. 1998. PMID: 9605754

6

B-cell development and maturation.

Rudin CM, Thompson CB. Rudin CM, et al. Among authors: thompson cb. Semin Oncol. 1998 Aug;25(4):435-46. Semin Oncol. 1998. PMID: 9728594 Review.

7

Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.

Kumar R, Mandal M, Lipton A, Harvey H, Thompson CB. Kumar R, et al. Among authors: thompson cb. Clin Cancer Res. 1996 Jul;2(7):1215-9. Clin Cancer Res. 1996. PMID: 9816290

8

Signal transduction pathways that regulate cell survival and cell death.

Dragovich T, Rudin CM, Thompson CB. Dragovich T, et al. Among authors: thompson cb. Oncogene. 1998 Dec 24;17(25):3207-13. doi: 10.1038/sj.onc.1202587. Oncogene. 1998. PMID: 9916983 Review.

9

Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck.

Pena JC, Thompson CB, Recant W, Vokes EE, Rudin CM. Pena JC, et al. Among authors: thompson cb. Cancer. 1999 Jan 1;85(1):164-70. doi: 10.1002/(sici)1097-0142(19990101)85:1<164::aid-cncr23>3.0.co;2-q. Cancer. 1999. PMID: 9921989

10

The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).

Chang BS, Kelekar A, Harris MH, Harlan JE, Fesik SW, Thompson CB. Chang BS, et al. Among authors: thompson cb. Mol Cell Biol. 1999 Oct;19(10):6673-81. doi: 10.1128/MCB.19.10.6673. Mol Cell Biol. 1999. PMID: 10490606 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters